Showing results (4591-4600 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 29, 2012
Colorectal cancer microenvironment: among nutrition, gut microbiota, inflammation and epigeneticsPaolo Garagnani, Chiara Pirazzini, Claudio FranceschiCurrent Pharmaceutical Design|November 3, 2012
Perspectives on new synthetic curcumin analogs and their potential anticancer propertiesAlok Vyas, Prasad Dandawate, Subhash Padhye, et al.Current Pharmaceutical Design|November 3, 2012
Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complicationsBo Meng, Jun Li, Hong CaoCurrent Pharmaceutical Design|November 3, 2012
Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs)Chengguang Zhao, Zhiguo Liu, Guang LiangCurrent Pharmaceutical Design|November 3, 2012
Riboflavin analogs as antiinfectives: occurrence, mode of action, metabolism and resistanceDanielle Biscaro Pedrolli, Frank Jankowitsch, Julia Schwarz, et al.Current Pharmaceutical Design|November 3, 2012
Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenaseMatheus Pinto Pinheiro, Flávio da Silva Emery, M Cristina NonatoCurrent Pharmaceutical Design|November 3, 2012
Biosynthesis of flavin cofactors in man: implications in health and diseaseMaria Barile, Teresa Anna Giancaspero, Carmen Brizio, et al.Current Pharmaceutical Design|February 18, 2015
Analysis of Edg-Like LPA Receptor-Ligand InteractionsBalazs Balogh, Tamas Pazmany, Peter MatyusCurrent Pharmaceutical Design|May 28, 2014
Impact of MCP-1 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie LuCurrent Pharmaceutical Design|March 4, 2015
Recombinant human serum albumin fusion proteins and novel applications in drug delivery and therapyBrian Rogers, Daoyuan Dong, Zhijun Li, et al.Pageof 1,008